The result suggested an explicit predictive value of ITGA1, ITGA2 or TEAD1 mRNA levels for patient prognosis in PCa group with a Gleason score of 7 (intermediate risk, Figure 10a–f), but not for the low‐risk cases with Gleason score ≤6 (Figure S11a–f, Supporting Information) nor high‐risk group with Gleason score ≥8 (Figure S11g–l, Supporting Information). The gene discussed is ITGA1; the disease is posterior cortical atrophy.